Neuro-Bio’s Founder & CEO Baroness Susan Greenfield was interviewed by Danilo di Diodoro, medical journalist and psychiatrist, highlighting our research into the T14 peptide and its potential role in the earliest stages of Alzheimer’s disease. As the field moves toward earlier detection and intervention, understanding mechanisms that precede amyloid and tau pathology is increasingly important.
We’re thrilled to see our work gaining international attention and to contribute to the evolving conversation around neurodegeneration.